CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Lundquist Kevin Michael Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-08-14 | KENYON LAWRENCE A Chief Financial Officer | Purchase | +101,010 | 106,956 | ||
| 2026-08-14 | KENYON LAWRENCE A Chief Financial Officer | Purchase · Warrants (right to buy) | +101,010 | 101,010 | ||
| 2026-08-14 | Jahr Robert Charles Chief Executive Officer | Purchase | +151,515 | 151,515 | ||
| 2026-08-14 | Jahr Robert Charles Chief Executive Officer | Purchase · Warrants (right to buy) | +151,515 | 151,515 | ||
| 2026-08-12 | Sukhtian Ghiath M. Director | Purchase | +2,525,252 | $0.99 | $2.5M | 24,617,320 |
| 2026-08-12 | Sukhtian Ghiath M. Director | Purchase · Warrants (right to buy) | +2,525,252 | 2,525,252 | ||
| 2026-07-29 | Sukhtian Faisal Ghiath Director | Purchase | +95,398 | $1.05 | $100K | 220,972 |
| 2026-07-21 | KENYON LAWRENCE A Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +210,078 | 210,078 | ||
| 2026-07-21 | Jahr Robert Charles Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-06-02 | Haddadin Yezan Munther Director | Purchase | +29,000 | $0.83 | $24K | 66,167 |
| 2026-05-28 | Sukhtian Ghiath M. Director | Purchase | +8,539,709 | $0.59 | $5.0M | 22,092,068 |
| 2026-05-28 | Sukhtian Ghiath M. Director | Other disposition · Warrants (right to buy) | −3,458,571 | 0 | ||
| 2026-05-28 | Sukhtian Ghiath M. Director | Purchase · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2026-05-28 | Sukhtian Ghiath M. Director | Other disposition · Warrants (right to buy) | −3,458,571 | 0 | ||
| 2026-05-28 | Sukhtian Ghiath M. Director | Purchase · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2026-05-28 | Sukhtian Ghiath M. Director | Other disposition · Warrants (right to buy) | −8,571,428 | 0 | ||
| 2026-05-28 | Sukhtian Ghiath M. Director | Purchase · Warrants (right to buy) | +8,571,428 | 8,571,428 | ||
| 2026-05-27 | Sukhtian Faisal Ghiath Director | Purchase | +122,174 | $0.41 | $50K | 125,574 |
| 2026-05-26 | Haddadin Yezan Munther Director | Purchase | +34,000 | $0.44 | $15K | 37,167 |
Page 1 of 8 · 142 trades